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Abstract  
BACKGROUND: Histiocytic sarcoma (HS) is an extremely rare, non-Langerhans cell tumor. HS affects especially 
adults, its etiology is unknown yet. Skin could be interested by papules or nodules, single or multiple.    
CASE REPORT: A Caucasian man in his late 40s came to our clinic for a naevi evaluation. During the visit, a 
rose papulonodular lesion was observed in the lumbar region. This lesion was completely asymptomatic, and it 
had been there for an indefinite period. The clinical evaluation revealed that the lesion appeared elevated, of 9 x 
15 mm in dimension, symmetrical and of a homogeneous pinkish colour. The videodermoscopical evaluation 
revealed a homogeneous yellow central pattern, polymorphic vessels, an eccentric peripheral pigmentation and a 
white collar. An excisional biopsy was performed. The morphology and the expression of CD163, CD68 and/or 
lysozyme to the immunophenotypic analysis, revealed the true nature of the lesion.  
CONCLUSION: HS is usually diagnosed at an already advanced clinical stage and it has a high mortality rate 
even today. Dermoscopy, showing a yellow and distributed homogeneously colour, can facilitate its hard 
diagnosis. 
 
 
 
 
 
Introduction 
 
Histiocytic sarcoma (HS) is an extremely rare, 
non-­‐Langerhans cell disorder with morphologic and 
immunophenotypic evidence of histiocytic disorders 
[1]. HS affects all ages, but it is more common in 
adults (46–55 years). The aetiology of this disorder is 
unknown [2]. Systemic symptoms (such as fever, night 
sweats, and weakness) and other skin, hepatosplenic 
or intestinal manifestations could appear. For some 
years there has been confusion about this type of a 
tumour and its terminology. Nonetheless, thanks to the 
advances in knowledge in the field of genetics and 
biology in recent years, we are today able to classify 
and recognize these kinds of hematologic neoplasms. 
The latest WHO classification of lymphomas, 
published in 2008 [3] and updated in 2016 [4], 
describes the HS within the histiocytic and dendritic 
cells neoplasms; this group includes pathologies 
which share the same functional properties of their 
normal counterpart (phagocytosis and/or processing 
and presentation of antigens) rather than their cell of 
origin [4]. 
 
 
Case Report 
 
A Caucasian man in his late 40s came to our 
clinic for a naevi evaluation.  
During the visit, a rose papulo-­‐nodular lesion 
was observed in the lumbar region (Figure 1: A, B). 
This lesion was completely asymptomatic, and it had 
been there for an indefinite period. The clinical 
evaluation showed that the lesion appeared elevated, 
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of 9x15 mm in dimension, symmetrical and a 
homogeneous pinkish colour.  
A)  
B)  
Figure 1: Clinical evaluation (A, B) 
 
Suspecting a malignant lesion, also a 
videodermoscopy of the lesion was also immediately 
performed, and this revealed a homogeneous yellow 
central pattern, polymorphic (arborizing, dotted and 
glomerular) vessels, an eccentric peripheral 
pigmentation and a white collar (Figure 2).  
 
Figure 2: Dermoscopic evaluation 
 
An excisional biopsy was performed. The 
morphology showed a diffuse proliferation of large 
cells, with grooved and indented nuclei and abundant 
eosinophilic cytoplasm (Figure 3: A, B). The 
immunochemistry of the surgical specimens showed 
cells with positivity for CD68, CD163 and CD4, with 
negativity for S100, CD34 and HMB45 (Figure 4). The 
Ki67 index was about 18% (Figure 4).  
 
Figure 3: Morphology 
 
The patient has always been in good health 
and was not taking any drugs. He had a skin type II 
according to Fitzpatrick’s classification; he did not 
suffer from any skin diseases and did not have 
melanoma familiarity. In the previous check-­‐ups of 
neavi no atypical lesions had been observed. 
  
  
Figure 4: Immunophenotype (first line, from left to right: CD4, CD68; 
second line, from left to right: CD163, Ki67). [Courtesy of Dr Mancini 
C., Unità Operativa di Anatomia e Istologia Patologica, Dipartimento 
Diagnostico, Università degli Studi di Parma] 
 
 
Discussion 
 
Even though the lymph nodes are the most 
common site of HS presentation, the gastrointestinal 
tract, the soft tissue and the skin could also be 
affected. Skin manifestations can be isolated or 
associated with systemic involvement. A cutaneous 
HS could appear as single or multiple papules and 
nodules of a light colour. The clinical differential 
diagnosis must take into account other cutaneous 
lesions: amelanotic melanoma, B or T cell lymphoma, 
dermatofibroma, dermatofibrosarcoma protuberans, 
juvenile xanthogranuloma, etc. 
With dermoscopy, the cutaneous HS is 
predominantly yellow, distributed homogeneously. 
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This colour, in dermoscopy, was investigated by 
Cavacchini et al. some years ago [5]. In the case of 
HS, the yellow may appear in various shades and is 
the background to some polymorphic vessels 
(arborising, dotted or glomerular) and a white-­‐pinkish 
collar. In fact, the presence of polymorphic vessels 
represents a highly risky dermoscopic pattern that can 
be seen not only in amelanotic melanoma or Spitz 
naevi [6] but also in other malignant lesions, such as 
an HS. When confronted with this kind of lesion, 
excisional biopsy is the most accurate diagnostic 
method. The morphology is characterized by large 
atypical pleomorphic cells with eosinophilic cytoplasm 
and large, round to oval, irregular nuclei [1]. 
The immunophenotype is characterized by the 
expression of one or more histiocytic markers, such as 
CD163, CD68 and lysozyme [1]. CD163, a 
haemoglobin scavenger receptor whose expression is 
limited to neoplasms of macrophage/histiocytic 
lineage, is more specific than CD68, and a strong 
immunoreactivity for this antigen is suggestive of 
histiocytic differentiation [2]. The Ki-­‐67 index is 
variable. Staging studies, including imaging studies 
such as computed tomography (CT) or a combined 
positron emission tomography (PET/CT), should be 
performed after the diagnosis to determine the extent 
of the disease. 
Unfortunately, HS is usually diagnosed at an 
already advanced clinical stage, and it does not have 
a good response to chemotherapy. This tumour has a 
high mortality rate and, in fact, most patients die from 
the progressive disease within two years [7]. 
Due to the aggressive course and the limited 
treatment options of this tumour, performing a careful 
clinical and dermoscopic evaluation is essential to help 
the final histological diagnosis. Over the last ten years, 
there has been various case reports in the literature 
regarding patients with cutaneous or subcutaneous 
histiocytic sarcoma. Only one of them [8] focused on 
the use of dermoscopy on this kind of lesion. 
Dermoscopy, a non-­‐invasive analysis 
technique, used especially for the early detection of 
melanoma, an instrument that is becoming 
increasingly widespread and more commonly used in 
dermatology clinics; it represents a tool which helps 
increase the low clinical sensitivity of the naked eye 
[9]. 
In conclusion, the early diagnosis of a rare 
and malignant tumour-like HS currently remains hard. 
However, dermoscopy can facilitate it and lead to 
quickly performing an excisional biopsy, thus 
improving the prognosis for patients. 
When dermoscopy notices the colours pink or 
black in a lesion, it should indicate to dermatologists 
that something may be wrong. Nevertheless, yellow 
too could be suspicious, and it is a wake-­‐up call in 
dermoscopy… beware of the “yellow submarine”! 
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